An in-depth look to GREENYN BIOTECHNOLOGY CO LTD operating, investing, and financing activities

6846 free cash flow for Q3 24 is 30.45 M TWD. For 2023, 6846 free cash flow was 38.19 M TWD and operating cash flow was 127.1 M TWD.